Serum Dupilumab Levels Do Not Predict Clinical Response in A

Researchers found no significant relationship between median week 16 dupilumab levels and 1-year clinical responses.

Related Keywords

Portland , Oregon , United States , Washington , Seattle , Leo Pharma , Robert Sidbury , Jonathani Silverberg , Lottes Spekhorst , Ericl Simpson , Sanofi Genzyme , Eli Lilly , Pfizer , George Washington University , Oregon Health Science University , National Expertise Center , University Medical Center Utrecht The Netherlands , Seattle Children , Atopic Dermatitis , University Medical Center Utrecht , Eczema Area , Severity Index , Oregon Health , Science University , Bioday Registry , Dermatitis , Biologic Therapy , Biomarker , Iological Marker , Blood , Tissue , Psoriasis , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Patient Safety , Adverse Effects , Side Effects , Children , Child , Childhood , Ediatrics , Kids , Clinical Research , Clinical Trials , Linical Studies , Cytokines , Eczema , Grant , Hospitals , Interleukins , Metabolism , Etabolic , Monoclonal A ,